Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boon Cher Goh

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
Journal of Cancer Research and Clinical Oncology|August 30, 2017
Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring systemJeremy Chee, Kwok Seng Loh, Ivan Tham, et al.
Journal of Clinical Pharmacology|November 12, 2013
CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patientsKok-Yong Seng, Kim-Hor Hee, Gaik Hong Soon, et al.
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|May 20, 2016
A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms)Mona S Calvo, Anita Mehrotra, Robert B Beelman, et al.
Acta Oncologica (Stockholm, Sweden)|April 25, 2007
Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinomaBenjamin Chuah, Robert Lim, Michael Boyer, et al.
Theranostics|January 6, 2022
The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapyJuan Li, Guo Zhang, Chen-Guang Liu, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2011
Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteersLingzhi Wang, Gaik Hong Soon, Kok-Yong Seng, et al.
Cytokine & Growth Factor Reviews|February 1, 2025
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapyWin Lwin Thuya, Yang Cao, Paul Chi-Lui Ho, et al.
Frontiers in Pharmacology|September 18, 2023
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trialsJiahui Yu, Mengnan Li, Boxu Ren, et al.
Blood|April 9, 2011
The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activityRathiga Velaithan, Jia Kang, Jayshree L Hirpara, et al.
American Journal of Clinical Oncology|April 2, 2004
Adjuvant high-dose rate brachytherapy after chemoradiation for treatment of early T-stage nasopharyngeal carcinomaJiade J Lu, Thomas Shakespeare, Boon Cher Goh, et al.
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
Journal of Cancer Research and Clinical Oncology|August 30, 2017
Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring systemJeremy Chee, Kwok Seng Loh, Ivan Tham, et al.
Journal of Clinical Pharmacology|November 12, 2013
CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patientsKok-Yong Seng, Kim-Hor Hee, Gaik Hong Soon, et al.
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|May 20, 2016
A Retrospective Study in Adults with Metabolic Syndrome: Diabetic Risk Factor Response to Daily Consumption of Agaricus bisporus (White Button Mushrooms)Mona S Calvo, Anita Mehrotra, Robert B Beelman, et al.
Acta Oncologica (Stockholm, Sweden)|April 25, 2007
Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinomaBenjamin Chuah, Robert Lim, Michael Boyer, et al.
Theranostics|January 6, 2022
The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapyJuan Li, Guo Zhang, Chen-Guang Liu, et al.
Antimicrobial Agents and Chemotherapy|July 13, 2011
Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteersLingzhi Wang, Gaik Hong Soon, Kok-Yong Seng, et al.
Cytokine & Growth Factor Reviews|February 1, 2025
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapyWin Lwin Thuya, Yang Cao, Paul Chi-Lui Ho, et al.
Frontiers in Pharmacology|September 18, 2023
Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trialsJiahui Yu, Mengnan Li, Boxu Ren, et al.
Blood|April 9, 2011
The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activityRathiga Velaithan, Jia Kang, Jayshree L Hirpara, et al.
American Journal of Clinical Oncology|April 2, 2004
Adjuvant high-dose rate brachytherapy after chemoradiation for treatment of early T-stage nasopharyngeal carcinomaJiade J Lu, Thomas Shakespeare, Boon Cher Goh, et al.
Pageof 25